These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 3115271

  • 1. Studies on the activity of L-threo-3,4-dihydroxyphenylserine (L-DOPS) as a catecholamine precursor in the brain. Comparison with that of L-dopa.
    Kato T, Karai N, Katsuyama M, Nakamura M, Katsube J.
    Biochem Pharmacol; 1987 Sep 15; 36(18):3051-7. PubMed ID: 3115271
    [Abstract] [Full Text] [Related]

  • 2. [Synthesis of norepinephrine from 3,4-dihydroxyphenylserine by L-aromatic amino acid decarboxylase of the rat brain and kidneys].
    Fujiwara H, Inagaki C, Ikeda Y, Tanaka C.
    Nihon Yakurigaku Zasshi; 1976 Oct 15; 72(7):891-8. PubMed ID: 14060
    [Abstract] [Full Text] [Related]

  • 3. DL-threo-DOPS as a precursor of noradrenaline.
    Reches A, Jackson-Lewis V, Fahn S.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov 15; 331(2-3):202-8. PubMed ID: 3937060
    [Abstract] [Full Text] [Related]

  • 4. Effect of L-threo-3,4-dihydroxyphenylserine(L-threo-DOPS) on brain and serum MHPG levels in mice: evidence for NE formation in CNS.
    Karai N, Kato T, Katsuyama M, Nakamura M, Katsube J.
    Life Sci; 1987 Jun 08; 40(23):2261-8. PubMed ID: 3108598
    [Abstract] [Full Text] [Related]

  • 5. Reversal of the reserpine-induced ptosis by L-threo-3,4-dihydroxy-phenylserine (L-threo-DOPS), a (-)-norepinephrine precursor, and its potentiation by imipramine or nialamide.
    Kato T, Katsuyama M, Karai N, Hirose A, Nakamura M, Katsube J.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar 08; 332(3):243-6. PubMed ID: 3086752
    [Abstract] [Full Text] [Related]

  • 6. The stereoisomers of 3,4-dihydroxyphenylserine as precursors of norepinephrine.
    Bartholini J, Constantinidis J, Puig M, Tissot R, Pletscher A.
    J Pharmacol Exp Ther; 1975 May 08; 193(2):523-32. PubMed ID: 1142103
    [Abstract] [Full Text] [Related]

  • 7. Increase in norepinephrine turnover after tyrosine or DL-threo-3,4-dihydroxyphenylserine (DL-threo-DOPS).
    Gibson CJ.
    Life Sci; 1988 May 08; 42(1):95-102. PubMed ID: 3121971
    [Abstract] [Full Text] [Related]

  • 8. A new metabolic pathway of L-threo-3,4-dihydroxyphenylserine, a precursor amino acid of norepinephrine, in the brain. Studies by in vivo microdialysis.
    Maruyama W, Nakahara D, Naoi M.
    J Neural Transm Park Dis Dement Sect; 1994 May 08; 7(1):21-33. PubMed ID: 8579767
    [Abstract] [Full Text] [Related]

  • 9. The effects of L-threo-dihydroxyphenylserine on norepinephrine metabolism in rat brain.
    Semba J, Takahashi R.
    Psychiatry Res; 1985 Aug 08; 15(4):319-26. PubMed ID: 3934694
    [Abstract] [Full Text] [Related]

  • 10. Enzymatic decarboxylation of L-threo-3,4-dihydroxyphenylserine in rat heart.
    Ohmura I, Inagaki C, Araki H, Tanaka C.
    Jpn J Pharmacol; 1978 Oct 08; 28(5):747-53. PubMed ID: 31501
    [Abstract] [Full Text] [Related]

  • 11. Studies on the central action of L-threo-3,4-dihydroxyphenyl-serine (L-threo-DOPS) in FLA-63-treated mice.
    Kato T, Katsuyama M, Karai N, Nakamura M, Katsube J.
    Pharmacol Biochem Behav; 1987 Feb 08; 26(2):407-11. PubMed ID: 3106991
    [Abstract] [Full Text] [Related]

  • 12. The metabolism of L-DOPA and L-threo-3,4-dihydroxyphenylserine and their effects on monoamines in the human brain: analysis of the intraventricular fluid from parkinsonian patients.
    Maruyama W, Naoi M, Narabayashi H.
    J Neurol Sci; 1996 Jul 08; 139(1):141-8. PubMed ID: 8836986
    [Abstract] [Full Text] [Related]

  • 13. L-DOPS-Accelerated recovery of locomotor function in rats subjected to sensorimotor cortex ablation injury: pharmacobehavioral studies.
    Kikuchi K, Nishino K, Ohyu H.
    Tohoku J Exp Med; 1999 Jul 08; 188(3):203-15. PubMed ID: 10587012
    [Abstract] [Full Text] [Related]

  • 14. Effect of L-threo-3,4-dihydroxyphenylserine (L-DOPS), an immediate precursor of norepinephrine, on the cerebral blood flow in rats.
    Sato E, Irie T, Katsube J.
    Jpn J Pharmacol; 1987 Jan 08; 43(1):91-3. PubMed ID: 3106684
    [Abstract] [Full Text] [Related]

  • 15. Effect of L-threo-3,4-dihydroxyphenylserine (L-DOPS) on catecholamine levels in plasma and cerebrospinal fluid (CSF) in anesthetized rats.
    Ishikawa Y, Kato Y, Murakami Y, Inoue T, Koshiyama H, Imura H.
    Proc Soc Exp Biol Med; 1987 Feb 08; 184(2):197-200. PubMed ID: 3101067
    [Abstract] [Full Text] [Related]

  • 16. Effects of L-threo-3,4-dihydroxyphenylserine on efflux of monoamines and acetylcholine in guinea pig brain.
    Nishino N, Fujii Y, Kondo M, Shuntoh H, Fujiwara H, Tanaka C.
    J Pharmacol Exp Ther; 1987 Aug 08; 242(2):621-8. PubMed ID: 3112367
    [Abstract] [Full Text] [Related]

  • 17. Diuretic effects of L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS) in anesthetized rats.
    Morimoto S, Matsumura Y, Ohyama T, Shinyama H, Ichihara T, Takahashi Y, Hisaki K.
    Jpn J Pharmacol; 1990 Mar 08; 52(3):431-9. PubMed ID: 2110272
    [Abstract] [Full Text] [Related]

  • 18. [Development of L-threo-DOPS, a norepinephrine precursor amino acid].
    Katsube J, Narabayashi H, Hayashi A, Tanaka C, Suzuki T.
    Yakugaku Zasshi; 1994 Nov 08; 114(11):823-46. PubMed ID: 7853146
    [Abstract] [Full Text] [Related]

  • 19. Substantial renal conversion of L-threo-3,4-dihydroxyphenylserine (droxidopa) to norepinephrine in patients with neurogenic orthostatic hypotension.
    Lamotte G, Holmes C, Sullivan P, Goldstein DS.
    Clin Auton Res; 2019 Feb 08; 29(1):113-117. PubMed ID: 30229336
    [Abstract] [Full Text] [Related]

  • 20. Preferential decarboxylation of L-threo-3,4-dihydroxyphenylserine in rat renal tissues.
    Soares-da-Silva P.
    Gen Pharmacol; 1993 Jan 08; 24(1):75-81. PubMed ID: 8482506
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.